Harmony Biosciences Management, Inc.
Clinical trials sponsored by Harmony Biosciences Management, Inc., explained in plain language.
Develops treatments for rare neurological diseases, including narcolepsy.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New pill aims to tame Narcolepsy's sleep attacks and sudden muscle weakness
Disease control Recruiting nowThis study tests whether HBS-301 (pitolisant) can reduce excessive daytime sleepiness and cataplexy (sudden muscle weakness) in adults with narcolepsy. Participants receive either the drug or a placebo for several weeks, followed by an open-label phase where everyone gets the dru…
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for chronic sleepiness: phase 3 drug trial launches
Symptom relief Recruiting nowThis study tests an experimental drug called HBS-301 to see if it can reduce symptoms of idiopathic hypersomnia, a condition causing severe daytime sleepiness, trouble waking up, and fatigue. About 248 adults with moderate to very severe symptoms will receive either the drug or a…
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New drug aims to tackle sleepiness in rare genetic disorder
Symptom relief Recruiting nowThis Phase 3 trial tests whether pitolisant can reduce excessive daytime sleepiness in people aged 6 and older with Prader-Willi syndrome. About 134 participants will receive either pitolisant or a placebo, and researchers will also look at effects on behavior and appetite. The s…
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Pregnancy safety of narcolepsy drug pitolisant under scrutiny
Knowledge-focused Recruiting nowThis study tracks pregnant women with narcolepsy who take pitolisant (Wakix) or other narcolepsy medications, as well as pregnant women without narcolepsy who take pitolisant. Researchers compare pregnancy outcomes, including birth defects, to see if the drug poses risks. The goa…
Sponsor: Harmony Biosciences Management, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC